[web_stories title="true" excerpt="false" author="false" date="false" archive_link="true" archive_link_label="" circle_size="150" sharp_corners="false" image_alignment="left" number_of_columns="1" number_of_stories="6" order="DESC" orderby="post_title" view="circles" /]
Oatly, Vita Coco, Tony’s Chocolonely, Who Gives A Crap, Pedego, Chewy.com, and Hint are just some of the well-known consumer brands that have received funding from Verlinvest in the past. Verlinvest is a family-backed, “evergreen,” growth fund investor that is now entering the venture capital industry.
After investing around €50 million in VC projects all over the world, it has decided to become the kick-starter limited partner in a new venture capital fund known as V3 Ventures, to invest up to €100 million in creators and brands directly.
Even though it will be completely separate from Verlinvest, V3 will still be able to take advantage of the latter’s extensive global network. The intention is to focus on pre-seed to Series A investments in entrepreneurs spanning e-commerce, health and beauty, and food and beverage industries in the United Kingdom (UK), Europe, the United States of America, and India. To this day, V3 Ventures has already put its money into the tailored cat food business Katkin, which is situated in the United Kingdom, the beauty firm Revea in the United States, and the supplement experts Culture in France.
The co-founder of V3 is Lopo Champalimaud, who previously established the online booking platform for hair and beauty services known as Treatwell after serving as the Managing Director of lastminute.com. I had the opportunity to discuss the transition with Champalimaud as well as the plans for V3’s business strategy. He told me, “I’ve got over 25 years of being an entrepreneur, and I figured the next 25 years helping entrepreneurs create their businesses.”
“With V3, we intend to make investments in firms that are focused on consumers, go worldwide, and place a significant amount of emphasis on ESG because that is where consumers are. It’s basically about trying to think about how the customer changes over time and staying ahead of that curve. Arjun Vaidya, who was instrumental in the sale of the D2C ayurvedic medicine brand to Dr. Vaidya’s brand, will be in charge of V3’s business dealings in India.
If you find the information presented here fascinating and would want to find out more, please return to this website on a regular basis to check for changes. Please visit journalworldwide.com if you are interested in obtaining background information or answers to any of the questions you have posed about this topic.
